These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17973948)

  • 41. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
    Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category.
    Weinberg OK; Hasserjian RP; Li B; Pozdnyakova O
    J Clin Pathol; 2017 Feb; 70(2):109-115. PubMed ID: 27387988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical analysis of HLA-DR-negative non-M3 AML].
    Mori H; Sakai H; Sanada M; Shimamoto K; Sasaki S; Azuma R; Higuchi T; Harada H; Niikura H; Omine M; Fujita K; Takahashi N
    Rinsho Ketsueki; 2007 Jul; 48(7):547-53. PubMed ID: 17695303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia.
    Shimoyama M; Yamamoto K; Nishikawa S; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2009 Oct; 194(1):38-43. PubMed ID: 19737652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
    Ohgami RS; Chisholm KM; Ma L; Arber DA
    Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia.
    Saini L; Brandwein J; Turner R; Larratt L; Hamilton M; Peters A; Wu C; Zhu N; Taparia M; Patterson JM; Bolster L; Mant M; Ritchie B; Liew E; Mirza I; Quest G; Nahirniak S; Ghosh S; Sandhu I
    Leuk Res; 2016 Jun; 45():47-52. PubMed ID: 27092851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
    Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
    Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cytology and immunophenotype feautures of 80 acute myeloid leukemia].
    Gouider E; Ayari S; Bouhoula S; Ben Abid H; Ali ZB; Meddeb B; Hafsia A; Hafsia R
    Tunis Med; 2007 May; 85(5):393-7. PubMed ID: 17657925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11.
    Sierra M; Hernández JM; García JL; Gutiérrez NC; Pérez JJ; Vidriales MB; Ramos F; Hernández JM; Romero M; González MB; Galende J; San Miguel JF
    Cancer Genet Cytogenet; 2005 Jul; 160(1):68-72. PubMed ID: 15949573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical nuclear positivity for WT1 in childhood acute myeloid leukemia.
    Al-Adnani M; Williams S; Anderson J; Ashworth M; Malone M; Sebire NJ
    Fetal Pediatr Pathol; 2007; 26(4):193-7. PubMed ID: 18075834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the translocation t(15;17) in acute myeloid leukemia (AML) initially classified as FAB M1: case report and review of the literature.
    Braham Jmili N; Omri H; Senana Sendi H; Fekih S; Hizem S; Sriha B; Khelif A; Saad A; Kortas M
    Clin Lab; 2006; 52(3-4):125-30. PubMed ID: 16584058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience.
    Yanada M; Suzuki M; Kawashima K; Kiyoi H; Kinoshita T; Emi N; Saito H; Naoe T
    Eur J Haematol; 2005 May; 74(5):418-23. PubMed ID: 15813916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
    Woźniak J; Kopeć-Szlezak J
    Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
    Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
    Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
    Willis MS; McKenna RW; Peterson LC; Coad JE; Kroft SH
    Am J Clin Pathol; 2005 Aug; 124(2):191-8. PubMed ID: 16040288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.